Ad-hoc | 13 November 2001 07:30

Eckert & Ziegler AG english

Eckert & Ziegler: Solid organic growth Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– Eckert & Ziegler: Solid organic growth EUR 0.95 net earnings per share in the first 9 months Berlin, November 13, 2001. Eckert & Ziegler AG, a specialist for sources of low level radiation sources, registered earnings after taxes totaling EUR 3.1 million with revenues of EUR 24.7 million in the first 9 months. The revenues for the previous year were thus exceeded by 55% and the result from the previous year by 175%. The projected performance for all of 2001 – EUR 3.2 million after taxes and EUR 1 per share – has thus nearly been reached after only three quarters. Revenues for the third quarter were 26% above the revenues posted in the previous year and are entirely attributable to organic growth, as the acquisitions which the company purchased in the United States at this time last year had already been fully integrated into the consolidated balance sheets. The oncology sector, up more than 70% as compared to the same quarter in the previous year, played a decisive role in this success. Due to the fact that the fourth quarter will still be burdened by the announced restructuring reserve of max. EUR 750,000, the Board of Directors will maintain the projected target of EUR 1 per share for the business year. The sales target of EUR 30 million will likely be exceeded, however. The Board of Directors For further information please contact: Karolin Riehle Investor Relations Eckert & Ziegler AG Robert-Rössle-Str. 10 D – 13125 Berlin http://www.ezag.com Tel.: +49 (0) 30 / 94 10 84-138 Fax.:+49 (0) 30 / 94 10 84-112 end of ad-hoc-announcement (c)DGAP 13.11.2001 ——————————————————————————– WKN: 565970; Index: Listed: Neuer Markt in Frankfurt; Freiverkehr in Berlin, Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart 130730 Nov 01